ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

An obvious next step in the development and growth of CAR T-cell therapies has been the jump to solid tumors. Because of ...

In a report released today, Ami Fadia from Needham maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report), with a price ...

Joseph Thome, an analyst from TD Cowen, maintained the Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report). The associated price ...

Intrathecal anesthesia is commonly associated with nausea post delivery; [1,2,3] however, the extent and duration of the nausea is usually short-lived and can be successfully treated with ...

The latest Ultragenyx corporate deck with these data updates can be accessed at . U.S. residents can learn more by visiting . GTX-102 is an investigational antisense oligonucleotide delivered via ...

Fidelis Animal Health, Inc. has received notification from the Food and Drug Administration (FDA) that Ethiqa XR (buprenorphine extended-release injectable suspension) 1.3 mg/mL is now indicated for ...

Despite diagnostic and therapeutic advances, mortality and the multi-systemic health impact of SMA continue to be experienced ...

Tetanus is a serious bacterial infection caused by Clostridium tetani, which affects the nervous system, leading to muscle stiffness and spasms. With an increased awareness of disease prevention, ...